PK/PD in Drug Discovery and Development MasterClass - US edition

This online masterclass will provide a review of the PK processes and of PD studies from a pharmacological perspective.

13-16 February, 2024, Virtual

Time Zone: Eastern Standard Time (EST) - UTC−05:00

Overview

The primary objective of PK/PD modeling is the prediction of the time course of the drug effect and its relation to dose and exposure. PK/PD modeling has become a key success factor in drug R&D. PK/PD represents and extremely useful tool for the selection of drug candidates, their optimization, and for maximal exploitation of early clinical studies for an optimal design of pivotal Phase 3 trials. PK/PD relies on prior in vitro bioassays, animal, and early clinical studies. PK/PD modeling is part of pharmacometrics and can be based also on the patho-physiological mechanisms and progression of the disease to predict therapeutic effects.

This comprehensive and detailed four half-day course describes the PK/PD studies from an industrial perspective to achieve a successful development program up to regulatory submission. The course is intended for those that have a previous background in PK/PD but also for those who wish to get a more in-depth training in PK/PD whilst not being specialists in the field.

#masterclass     #glceurope      #pharmaonlinetraining      #globalleadingconferences       #PKPDdrugdiscovery

RECOMMENDATION

Who should attend?

This course has been specifically designed to address the needs of those working in
the following areas:

• Regulatory

• Medical Affairs

• Licensing

• Project Management

• Outsourcing

• Pre-clinical Discovery and Development

• Clinical Research and Development

• Medical Writing